AdaptHealth (AHCO)
(Real Time Quote from BATS)
$9.53 USD
+0.45 (4.96%)
Updated Aug 8, 2024 12:06 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Income Statements
Fiscal Year end for AdaptHealth Corp falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 3,200 | 2,971 | 2,465 | 1,071 | 530 |
Cost Of Goods | 2,721 | 2,553 | 2,009 | 899 | 440 |
Gross Profit | 480 | 417 | 456 | 172 | 89 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,078 | 227 | 231 | 101 | 60 |
Income After Depreciation & Amortization | -598 | 190 | 226 | 71 | 30 |
Non-Operating Income | 5 | 17 | 61 | -101 | -2 |
Interest Expense | 130 | 109 | 95 | 41 | 39 |
Pretax Income | -724 | 98 | 191 | -71 | -12 |
Income Taxes | -49 | 25 | 33 | -12 | 1 |
Minority Interest | 4 | 4 | 2 | 6 | 2 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -675 | 73 | 158 | -59 | -13 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -679 | 69 | 156 | -64 | -15 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 620 | 547 | 489 | 161 | 96 |
Depreciation & Amortization (Cash Flow) | 1,219 | 356 | 263 | 90 | 66 |
Income After Depreciation & Amortization | -598 | 190 | 226 | 71 | 30 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 134.42 | 138.99 | 133.03 | 52.49 | 22.56 |
Diluted EPS Before Non-Recurring Items | 1.02 | 0.28 | 0.67 | 0.43 | 0.30 |
Diluted Net EPS (GAAP) | -5.31 | 0.33 | 0.67 | -1.23 | -0.66 |
Fiscal Year end for AdaptHealth Corp falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 792.50 | 858.23 | 804.03 | 793.29 |
Cost Of Goods | NA | 675.69 | 698.33 | 693.49 | 673.40 |
Gross Profit | NA | 116.80 | 159.90 | 110.54 | 119.89 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 66.28 | 377.70 | 571.58 | 65.63 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 50.52 | -217.80 | -461.04 | 54.26 |
Non-Operating Income | NA | -12.56 | -20.40 | 5.84 | -1.27 |
Interest Expense | NA | 32.47 | 33.49 | 32.31 | 32.55 |
Pretax Income | NA | 5.50 | -271.69 | -487.50 | 20.44 |
Income Taxes | NA | 6.61 | -18.11 | -34.58 | 5.40 |
Minority Interest | NA | 1.03 | 0.93 | 1.16 | 1.06 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1.11 | -253.58 | -452.92 | 15.04 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -2.13 | -254.50 | -454.08 | 13.98 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 132.91 | 132.99 | 134.98 | 136.23 |
Diluted EPS Before Non-Recurring Items | NA | 0.02 | 0.64 | 0.19 | 0.16 |
Diluted Net EPS (GAAP) | NA | -0.02 | -1.91 | -3.43 | 0.09 |